Clinical trial
Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients: Retrospective Analysis in a Prospective National Cohort Study (RAL-LT-HIV)
NCT02995824 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients: Retrospective Analysis in a Prospective National Cohort Study (RAL-LT-HIV)
- Lead sponsor
- Hospital Clinic of Barcelona
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2002
- Completion date
- December 31, 2019
- Enrollment
- 271 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
antiretroviral therapy, hiv infections, liver transplantation